Skip to main content
Log in

Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Vulvovaginal candidiasis (VVC) is one of the most frequent female genital disorders and Candida glabrata is the second most common agent. Current study was aimed to study the susceptibility to antifungal agents of C. glabrata isolated from vaginal samples and some virulence attributes in order to better understand why this species is emerging as the main VVC agents.

Methods

A total of 60 C. glabrata vaginal isolates were included in this study. Firstly they were screened by susceptibility tests to antifungal agents. The isolates that showed sensitivity or resistance to fluconazole were evaluated for their virulence potential, including ability to adhere to polystyrene and vaginal ring, cell surface hydrophobicity (CSH) and capacity to form biofilm.

Results

Candida glabrata isolates varied significantly in adherence capacity, biofilm formation and CSH. However, it was possible to observe that isolates resistant to fluconazole adhered more efficiently to the vaginal ring and were statistically more able to form biofilm.

Conclusion

These results allow hypothesizing that C. glabrata is an emergent agent in VVC probably because the treatment with fluconazole selects this species. But once adhered, yeasts remain on biotic or abiotic surfaces causing colonization or VVC symptomatology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Liu XP, Fan SR, Peng YT, Zhang HP (2014) Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. J Mycol Med. doi:10.1016/j.mycmed.2014.01.060

    PubMed  Google Scholar 

  2. Kumari F, Banerjee T, Kumar P, Pandey S, Tilak R (2013) Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India. Indian J Pathol Microbiol. doi:10.4103/0377-4929.118703

    PubMed  Google Scholar 

  3. Ogouyèmi-Hounto A, Adisso S, Djamal J, Sanni R, Amangbegnon R, Biokou-Bankole B et al (2014) Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. J Mycol Med. doi:10.1016/j.mycmed.2014.01.003

    PubMed  Google Scholar 

  4. Maria C, Zahra R, Sara P (2013) Prevalence of cervical-vaginal infections in the pap-smear samples in Iran. Glob J Health Sci. doi:10.5539/gjhs.v6n1p201

    PubMed  PubMed Central  Google Scholar 

  5. Gunther LSA, Martins HPR, Gimenes F, Abreu ALPD, Consolaro MEL, Svidzinski TIE (2014) Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women. Sao Paulo Med J 132(2):116–120

    Article  PubMed  Google Scholar 

  6. Babin D, Kotigadde S, Rao PS, Rao TV, Babin MD (2013) Clinico-mycological profile of vaginal candidiasis in a tertiary care hospital in Kerala. Int J Res Biol Sci 3:55–59

    Google Scholar 

  7. Hamad M, Kazandji N, Awadallah S, Allam H (2014) Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses. doi:10.1111/myc.12141

    PubMed  Google Scholar 

  8. Fan SR, Liu XP, Li JW (2008) Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J Obstet Gynaecol Res. doi:10.1111/j.1447-0756.2008.00817.x

    PubMed  Google Scholar 

  9. Martins HPR, Da Silva MC, Paiva LCF, Svidzinski TIE, Consolaro MEL (2012) Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. Acta Derm Venereol. doi:10.2340/00015555-1194

    PubMed  Google Scholar 

  10. Kennedy MA, Sobel JD (2010) Vulvovaginal candidiasis caused by non-albicans Candida species: new insights. Curr Infect Dis Rep. doi:10.1007/s11908-010-0137-9

    PubMed  Google Scholar 

  11. Ragunathan L, Poongothai GK, Sinazer AR, Kannaiyan K, Gurumurthy H, Jaget N et al (2014) Phenotypic characterization and antifungal susceptibility pattern to fluconazole in Candida species isolated from vulvovaginal candidiasis in a tertiary care hospital. J Clin Diagn Res 8(5):DC01–DC04. doi:10.7860/JCDR/2014/7434.4311

    PubMed  PubMed Central  Google Scholar 

  12. Alfouzan W, Dhar R, Ashkanani H, Gupta M, Rachel C, Khan ZU (2015) Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait. J Mycol Med 25(1):23–28. doi:10.1016/j.mycmed.2014.10.021

    Article  CAS  PubMed  Google Scholar 

  13. Payne MS, Cullinane M, Garland SM, Tabrizi SN, Donath SM, Bennett CM et al (2015) Detection of Candida spp. in the vagina of a cohort of nulliparous pregnant women by culture and molecular methods: is there an association between maternal vaginal and infant oral colonisation? Aust N Z J Obstet Gynaecol 56(2):179–184. doi:10.1111/ajo.12409 (Epub 2015 Oct 5)

    Article  PubMed  Google Scholar 

  14. Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY (2016) Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida isolates in China. Chin Med J (Engl) 129(10):1161–1165. doi:10.4103/0366-6999.181964

    Article  Google Scholar 

  15. Alczuk SDSD, Bonfim-Mendonca PS, Rocha-Brischiliari SC, Shinobu-Mesquita CS, Martins HPR, Gimenes F et al (2015) Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected women. Rev Inst Med Trop Sao Paulo 57(2):169–174. doi:10.1590/S0036-46652015000200012

    Article  CAS  PubMed Central  Google Scholar 

  16. Consolaro MEL, Albertoni TA, Yoshida CS, Mazucheli J, Peralta RM, Svidzinski TIE (2004) Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil. Rev Iberoam Micol 21:202–205

    Google Scholar 

  17. Irie MMT, Consolaro MEL, Guedes TE, Donatti L, Patussi VE, Svidzinski TIE (2006) A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells. J Clin Lab Anal 20:195–203

    Article  Google Scholar 

  18. Camacho DP, Consolaro MEL, Patussi EV, Donatti L, Gasparetto A, Svidzinski TIE (2007) Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 76:439–443

    Article  CAS  PubMed  Google Scholar 

  19. Paiva LCF, Donatti L, Patussi EV, Svizdinski TIE, Consolaro MEL (2010) Scanning electron and confocal scanning laser microscopy imaging of the ultrastructure and viability of vaginal Candida albicans and non-albicans species adhered to an intrauterine contraceptive device. Microsc Microanal. doi:10.1017/S1431927610093773

    PubMed  Google Scholar 

  20. Bonfim-Mendonça PS, Ratti BA, Godoy JSR, Negri M, Lima NCA, Fiorini A et al (2014) β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. PLoS One. doi:10.1371/journal.pone.0107805

    PubMed Central  Google Scholar 

  21. Institute CaLS (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts M27-A3, 3rd edn. Clinical and Laboratory Standards Institute, Wayne

    Google Scholar 

  22. European Committee on Antimicrobial Susceptibility (2010) T. EUCAST clinical breakpoints, Verfügbar unter. http://www.eucast.org/clinical_breakpoints. Accessed 18 Oct 2012

  23. Raut J, Rathod V, Karuppayil SM (2010) Cell surface hydrophobicity and adhesion: a study on fifty clinical isolates of Candida albicans. Nihon Ishinkin Gakkai Zasshi 51:131–136

    Article  PubMed  Google Scholar 

  24. Negri M, Gonçalves VM, Silva SC, Henriques M, Azeredo J, Oliveira R (2010) Crystal violet staining to quantity Candida adhesion to epithelial cells. Br J Biomed Sci. doi:10.1080/09674845.2010.11730308

    PubMed  Google Scholar 

  25. Santander MP (2016) Identificación y sensibilidad antifúngica in vitro de Candida spp. de origen vaginal a fluconazol, clotrimazol y nistatina. Quimioterapia 29:151–154

    Google Scholar 

  26. Santos ER, Forno CFD, Hernandez MG, Kubiça TF, Venturini TP, Chassot F et al (2014) Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints. Rev Inst Med Trop São Paulo 56:477–482

    Article  PubMed  PubMed Central  Google Scholar 

  27. Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA et al (2006) Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J Infect 52:111–117

    Article  PubMed  Google Scholar 

  28. Dalben-Dota KF, Faria MGI, Bruschi ML, Pelloso SM, Consolaro MEL, Svidzinski TIE (2010) Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. J Altern Complement Med. doi:10.1089/acm.2009.0281

    PubMed  Google Scholar 

  29. Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S (2016) Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. doi:10.3109/1040841X.2015.1091805

    PubMed  Google Scholar 

  30. Gómez-Molero E, Boer AD, Dekker HL, Moreno-Martínez A, Kraneveld EA, Chauhan N et al (2015) Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins. FEMS Yeast Res. doi:10.1093/femsyr/fov098

    PubMed  Google Scholar 

  31. Doyle RJ (2000) Contribution of the hydrophobic effect to microbial infection. Microbes Infect 4:391–400

    Article  Google Scholar 

  32. Camacho DP, Gasparetto A, Svidzinski TIE (2007) The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia 163:261–266

    Article  CAS  PubMed  Google Scholar 

  33. Paiva LCF, Vidigal PG, Donatti L, Svidzinski TIE, Consolaro MEL (2012) Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron. doi:10.1016/j.micron.2011.09.013

    PubMed  Google Scholar 

  34. Vitali A, Vavala E, Marzano V, Leone C, Castagnola M, Lavarone F et al (2016) Cell wall composition and biofilm formation of azoles-susceptible and-resistant Candida glabrata strains. J Chemother. doi:10.1080/1120009X.2016.1199507

    PubMed  Google Scholar 

  35. Samaranayake LP, Fidel PL, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E et al (2002) Fungal infections associated with HIV infection. Oral Dis 8:151–160

    Article  PubMed  Google Scholar 

  36. El-Kirat-Chatel S, Beaussart A, Derclaye S, Alsteens D, Kucharikova S, Dijck PV et al (2015) Force nanoscopy of hydrophobic interactions in the fungal pathogen Candida glabrata. ACS Nano. doi:10.1021/nn506370f

    PubMed  Google Scholar 

  37. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP (2008) Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother. doi:10.1128/AAC.00541-08

    PubMed  PubMed Central  Google Scholar 

  38. Rodrigues CF, Silva S, Henriques M (2013) Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-013-2009-3

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Programa Nacional de Cooperação Acadêmica (CAPES/PNPD) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (Cnpq) by financial support.

Author information

Authors and Affiliations

Authors

Contributions

SSNV: project development, data collection, manuscript writing and editing. AF: project development, data collection and management, manuscript editing. PDZ: project development, data analysis, manuscript editing. PSBM: project development, data collection. JRG: project development, data collection. AA: project development, data collection. MELC: project design, data analysis, financial support. TIES: project design and management, data analysis, financial support, manuscript writing and editing.

Corresponding author

Correspondence to Terezinha Inez Estivalet Svidzinski.

Ethics declarations

Funding

This study was funded by Programa Nacional de Cooperação Acadêmica (CAPES/PNPD) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (Cnpq).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional (Committee of the State University of Maringá—number 185/2007) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura-Vasconcelos, S.S., Fiorini, A., Zanni, P.D. et al. Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?. Arch Gynecol Obstet 296, 519–526 (2017). https://doi.org/10.1007/s00404-017-4465-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-017-4465-y

Keywords

Navigation